JEFFREY ALAN KERN
Medical Practice in Iowa City, IA
License number
Pennsylvania MD027372E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Iowa City, IA 52246
Pennsylvania
Pennsylvania
Professional information
Use Of Heregulin As A Growth Factor
US Patent:
7153828, Dec 26, 2006
Filed:
Jun 3, 2003
Appl. No.:
10/453183
Inventors:
Mark X. Sliwkowski - San Carlos CA, US
Jeffrey A. Kern - Iowa City IA, US
Jeffrey A. Kern - Iowa City IA, US
Assignee:
Genentech, Inc. - South San Francisco CA
University of Iowa Research Foundation - Iowa City IA
University of Iowa Research Foundation - Iowa City IA
International Classification:
C07K 14/475, A61K 38/18
US Classification:
514 12, 530399, 435377
Abstract:
Ligands which bind to the HER2, HER3 and/or HER4 receptors are useful as normal epithelial cell growth factors.
Use Of Heregulin As A Growth Factor
US Patent:
2001002, Sep 20, 2001
Filed:
Feb 2, 2001
Appl. No.:
09/773517
Inventors:
Mark Sliwkowski - San Carlos CA, US
Jeffrey Kern - Iowa City IA, US
Jeffrey Kern - Iowa City IA, US
International Classification:
A61K038/16
US Classification:
514/002000, 424/093700
Abstract:
Ligands which bind to the HER2, HER3 and/or HER4 receptors are useful as normal epithelial cell growth factors.
Use Of Heregulin As A Growth Factor
US Patent:
2002004, Apr 11, 2002
Filed:
Feb 23, 2001
Appl. No.:
09/792025
Inventors:
Mark Sliwkowski - San Carlos CA, US
Jeffrey Kern - Iowa City IA, US
Jeffrey Kern - Iowa City IA, US
International Classification:
A01N037/18, A61K038/00, G01N033/574, C07K001/00, C07K014/00, C07K017/00
US Classification:
435/007230, 530/351000, 514/002000
Abstract:
Ligands which bind to the HER2, HER3 and/or HER4 receptors are useful as normal epithelial cell growth factors.